2.4.2025 13:43:50 CEST | Demant A/S |
Ledende medarbejderes transaktioner
Selskabsmeddelelse nr. 2025-05
2. april 2025
Ledende medarbejderes og disses nærtståendes transaktioner med Demant-aktier
Indberetning i henhold til markedsmisbrugsforordningens artikel 19.
1.
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)
Navn
Søren Nielsen
2.
Årsag til indberetningen
a)
Stilling/titel
Koncernchef og administrerende direktør
b)
Første indberetning/ændring
Første indberetning
3)
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)
Navn
Demant A/S
b)
LEI-kode
213800RM6L9LN78BVA56
4.
Nærmere oplysninger om transaktionen/transaktionerne: Gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)
Beskrivelse af det finansielle
instrument, instrumenttypen
Identifikationskode
Aktier
DK0060738599
b)
Transaktionens art
Levering af aktier ved optjening af RSU’er tildelt under det langsigtede incitamentsprogram
c)
Pris(er) og mængde(r)
Pris(er) Mængde(r)
DKK 0 pr. aktie 18.658 stk. aktier
d)
Aggregerede oplysninger:
– Aggregeret mængde
– Pris
Aggregeret mængde: 18.658 stk. aktier
Samlet pris: DKK 0
e)
Dato for transaktionen
1. april 2025
f)
Sted for transaktionen
Uden for marked
1.
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)
Navn
René Schneider
2.
Årsag til indberetningen
a)
Stilling/titel
CFO
b)
Første indberetning/ændring
Første indberetning
3)
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)
Navn
Demant A/S
b)
LEI-kode
213800RM6L9LN78BVA56
4.
Nærmere oplysninger om transaktionen/transaktionerne: Gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)
Beskrivelse af det finansielle
instrument, instrumenttypen
Identifikationskode
Aktier
DK0060738599
b)
Transaktionens art
Levering af aktier ved optjening af RSU’er tildelt under det langsigtede incitamentsprogram
c)
Pris(er) og mængde(r)
Pris(er) Mængde(r)
DKK 0 pr. aktie 8.470 stk. aktier
d)
Aggregerede oplysninger:
– Aggregeret mængde
– Pris
Aggregeret mængde: 8.470 stk. aktier
Samlet pris: DKK 0
e)
Dato for transaktionen
1. april 2025
f)
Sted for transaktionen
Uden for marked
1.
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)
Navn
Niels Wagner
2.
Årsag til indberetningen
a)
Stilling/titel
President of Hearing Care
b)
Første indberetning/ændring
Første indberetning
3)
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)
Navn
Demant A/S
b)
LEI-kode
213800RM6L9LN78BVA56
4.
Nærmere oplysninger om transaktionen/transaktionerne: Gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)
Beskrivelse af det finansielle
instrument, instrumenttypen
Identifikationskode
Aktier
DK0060738599
b)
Transaktionens art
Levering af aktier ved optjening af RSU’er tildelt under det langsigtede incitamentsprogram
c)
Pris(er) og mængde(r)
Pris(er) Mængde(r)
DKK 0 pr. aktie 7.096 stk. aktier
d)
Aggregerede oplysninger:
– Aggregeret mængde
– Pris
Aggregeret mængde: 7.096 stk. aktier
Samlet pris: DKK 0
e)
Dato for transaktionen
1. april 2025
f)
Sted for transaktionen
Uden for marked
Yderligere information:
Peter Pudselykke, Head of Investor Relations
Henrik Axel Lynge Buchter, Communication Manager
Telefon: +45 3917 7300
www.demant.com
Kontakter
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2025-05 Ledende medarbejderes og disses nærtståendes transaktioner med Demant-aktier.pdf
2.4.2025 13:43:50 CEST | Demant A/S |
Managers' Transactions
Company announcement no 2025-05
2 April 2025
Transactions with Demant shares by managers and closely related parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Søren Nielsen
2.
Reason for the notification
a)
Position/status
President & CEO
b)
Initial notification/amendment
First notification
3)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Delivery of shares upon vesting of RSUs granted under the Long-term Incentive Programme
c)
Price(s) and volume(s)
Price(s) Volume(s)
DKK 0 per share 18,658 shares
d)
Aggregated information:
– Aggregated volume
– Price
Aggregated volume: 18,658 shares
Total price: DKK 0
e)
Date of the transaction
1 April 2025
f)
Place of the transaction
Outside of trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
René Schneider
2.
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/amendment
First notification
3)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Delivery of shares upon vesting of RSUs granted under the Long-term Incentive Programme
c)
Price(s) and volume(s)
Price(s) Volume(s)
DKK 0 per share 8,470 shares
d)
Aggregated information:
– Aggregated volume
– Price
Aggregated volume: 8,470 shares
Total price: DKK 0
e)
Date of the transaction
1 April 2025
f)
Place of the transaction
Outside of trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Niels Wagner
2.
Reason for the notification
a)
Position/status
President of Hearing Care
b)
Initial notification/amendment
First notification
3)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Delivery of shares upon vesting of RSUs granted under the Long-term Incentive Programme
c)
Price(s) and volume(s)
Price(s) Volume(s)
DKK 0 per share 7,096 shares
d)
Aggregated information:
– Aggregated volume
– Price
Aggregated volume: 7,096 shares
Total price: DKK 0
e)
Date of the transaction
1 April 2025
f)
Place of the transaction
Outside of trading venue
Further information:
Peter Pudselykke, Head of Investor Relations
Henrik Axel Lynge Buchter, Communication Manager
Phone: +45 3917 7300
www.demant.com
Contacts
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2025-05 Managers and closely related parties transactions with Demant shares.pdf
